I. Introduction
The term pterygium comes from the ancient Greek word (pteryx) = wing and (gion) = fin. Pterygium is characterized by a triangular portion of the bulbar conjunctiva encroaching onto the cornea. It is believed that pterygium is growth disorder characterized by conjunctivalisation of the cornea due to localized ultraviolet rays stimulated damage to the limbal stem cells. Destructive pterygial fibroblasts are also responsible for corneal invasion Pterygium is more often seen in men than in women. This is attributed to the fact that males are exposed to dust and environmental irritants more than women. Usually seen within the interpalpebral fissure and most often on the nasal side . The nasal affinity of the pterygium is attributed to the following factors. Sparseness of the subconjunctival tissue in the temporal region , exposed to a lesser extent to UV radiation due to greater amount of bowing of outer 2/3 of the upper lids. The prevalence rate of primary pterygium varies from 0.7 to 3.1% in various populations around the world. Patient may have foreign body sensation, discomfort, congestion (redness), irritation, grittiness, blurring of vision either because of induced astigmatism or obscuring visual axis.
Indications for surgery include cosmetic disfigurement, recurrent inflammation, interference with contact lens wear ,motility restriction and rarely, changes suggestive of neoplasia. But patient should be explained that there is fairly high risk of recurrence which may be more unsightly. To prevent recurrence conjunctival auto grafting either by use of fibrin glue or sutures is being used. In this study the possibility of blood ooze during the pterygium excision used as a tissue adhesive to secure the conjunctival autograft was studied.
II. Method
All the cases had informed written consent and hospital ethical committee approval for study. 
III. Surgial Technique
All patients were anaesthetized with a peribulbar block and then eyes were painted and draped. The fibrotic tissue was extensively dissected to expose the sclera and corneal stroma. The subconjuctival fibrovascular tissue, including tenon's capsule, were thoroughly removed to provide clean scleral bed. The size of the defect is measured with calipers. Around 0.5mm more than the measured defect marking is done on supero temporal conjunctiva. A thin film of blood clot is allowed to form over the bare sclera. Any active bleeding is stopped by direct tamponade. A thin tenon free conjunctival auto graft with limbal stem cell is excised. Auto graft is slided over the cornea, orientation is kept limbus to limbus. It is slipped over with draping motion to ensure epithelial side is up. After placement of graft over the bare sclera with oozed blood during excision gently press for 3-5 minutes. The stabilization of graft is tested centrally and on each free edge to ensure firm adherence to sclera.At the end of surgery carefully eye speculum was removed without distorting graft.Eye is patched for 12-24 hours.
Routine post op instructions like tapered 1% Prednisolone acetate eye drops 4-6 time daily for3-4 weeks, Moxifloxacin eye drops for 7 days .Lubricating eye drops for 6-8 weeks are used .Patients follow up for 1 st day ,1 week,4 weeks and 12 weeks. 
Results

Primary outcome
IV. Discussion
Pterygium surgery should ideally have a low or no recurrence, minimal complications and be cosmetically acceptable. Current surgical methods to prevent pterygium recurrence include conjunctival autograft, and limbal-conjunctival transplant, conjunctival flap and conjunctival rotation autograft surgery, amniotic membrane transplant, cultivated conjunctival transplant, lamellar keratoplasty, and the use of fibrin glue. All of these techniques involve the use of sutures or fibrin glue and are therefore vulnerable to associated complications.
